title: Low molecular weight heparin as thromboprophylaxis throughout pregnancy in heritable thrombophilic women.
authors.forename: Z
authors.initials: Z
authors.lastname: Boda
authors.forename: P
authors.initials: P
authors.lastname: László
authors.forename: G
authors.initials: G
authors.lastname: Pfliegler
authors.forename: I
authors.initials: I
authors.lastname: Tornai
authors.forename: L
authors.initials: L
authors.lastname: Rejtö
authors.forename: A
authors.initials: A
authors.lastname: Schlammadinger
mesh_terms: D000328:Adult; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D011256:Pregnancy Outcome; D019851:Thrombophilia / Q000188:drug therapy* / Q000235:genetics; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight